1 / 4

Pain Management Therapeutics Market

Pain Management Therapeutics Market

15118
Download Presentation

Pain Management Therapeutics Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pain Management Therapeutics Market 2020 Analysis Research and Development Forecast by 2025 The pain management therapeutics market is segmented on the lines of its therapeutics, indication and regional. Based on therapeutics segmentation it covers antimigraine agents, non steroidal anti inflammatory drugs, anesthetics, antidepressants, anticonvulsants, opioids and other non narcotic analgesic. Opioidsis further segmented into tramadol, hydrocodones, oxycodaones and others such as methadone, meperidine, fentanyl, codeine, morphine. Based on indication segmentation the pain management therapeutics market covers cancer pain, post operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia and neuropathic pain. The pain management therapeutics marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. Browse Full Report @:https://www.marketresearchengine.com/reportdetails/pain- management-therapeutics-market The pain management therapeutics market is expected to exceed more than US$ 83 Billion by 2024; Growing at a CAGR of more than 3.5% in the given forecast period. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments. The scope of the report includes a detailed study of global and regional markets for pain management therapeutics market with the reasons given for variations in the growth of the industry in certain regions. Pain management is one of the branch of medicine which utilizes an inter punitive approach for improving the superiority and easing the suffering of life of persons who are living with the chronic pain. The usual pain management group consists of clinical psychologists, clinical nurse specialists, physician assistants, occupational therapists, physiotherapists, pharmacists and medical practitioners. Market analyst proposes that almost 20% of world’s population currently suffers from chronic pain. Factors that are increasing number of surgeries, changing lifestyle, increasing geriatric population and increasing prevalence of chronic diseases are responsible for growth in new patients every year.

  2. The major driving factors of pain management therapeutics market are as follows: Approving health care reforms and regulatory scenario Increasing approval of pain management therapeutics between end users Increasing in geriatric population with high risk of different diseases Growing frequency of chronic pain disorders The restraining factors of pain management therapeutics market are as follows: Enduring pain relief from medical devices, alternative therapies and surgical procedures Prescription drug exploitation Exclusive rights expiry of entry of generics and key drugs The Pain management therapeutics Market has been segmented as below: The Pain management therapeutics Market is Segmented on the lines of Therapeutics Analysis, Indication Analysis and Regional Analysis. By Therapeutics Analysis this market is segmented on the basis of Antimigraine agents, Non steroidal anti inflammatory drugs, Anesthetics, Antidepressants, Anticonvulsants, Opioids, Tramadol, Hydrocodones, Oxycodaones, Others (Methadone, Meperidine, Fentanyl, Codeine, Morphine) and Other non narcotic analgesic. By Indication Analysis this market is segmented on the basis of Cancer pain, Post operative pain, Migraine, Arthritic pain, Chronic back pain, Fibromyalgia and Neuropathic pain. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World. This report provides: 1) An overview of the global market for pain management therapeutics and related technologies. 2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024. 3) Identifications of new market opportunities and targeted promotional plans for pain management therapeutics. 4) Discussion of research and development, and the demand for new products and new applications. 5) Comprehensive company profiles of major players in the industry. Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/pain-management-therapeutics- market

  3. Table of Contents 1. INTRODUCTION 2 Research Methodology 3. Global Pain Management Therapeutics Market – Industry Analysis 4. North America Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024 5. Europe Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024 6. Asia Pacific Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024 7. Rest of World Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024 8. Country Snippet 9. Company Profiles 9.1. Abbott Laboratories 9.2. AstraZeneca 9.3. Depomed, Inc. 9.4. Endo Pharmaceuticals, Inc. 9.5. GlaxoSmithKline plc 9.6. Johnson & Johnson 9.7. Mallinckrodt Pharmaceuticals 9.8. Merck & Co., Inc. 9.9. Novartis AG 9.10. Pfizer, Inc. 9.11. Purdue Pharma L.P. 9.12. Teva Pharmaceutical Industries Limited Other Related Market Research Reports:

  4. Patient Monitoring Devices Equipments Systems Market is Determined to Grow US$ 30000 million by 2024 PCR Devices Market is Projected to Reach US$ 5.00 Billion by 2024 Peripheral Vascular & Interventional Cardiology Devices Market is Determined to Cross US$ 25 Billion by 2022 Media Contact Company Name: Market Research Engine Contact Person: John Bay Email: john@marketresearchengine.com Phone: +1-855-984-1862 Country: United States Website: https://www.marketresearchengine.com/ Source: http://heraldkeeper.com

More Related